Mawer Investment Management’s CRH Medical Corporation CRHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-428,400
Closed -$1.72M 115
2018
Q3
$1.72M Sell
428,400
-3,290,030
-88% -$12.1M 0.01% 103
2018
Q2
$11.6M Sell
3,718,430
-2,127,519
-36% -$6.79M 0.09% 90
2018
Q1
$14.8M Sell
5,845,949
-104,870
-2% -$294K 0.12% 85
2017
Q4
$15.7M Sell
5,950,819
-12,700
-0.2% -$28.3K 0.13% 90
2017
Q3
$15.5M Buy
5,963,519
+1,221,028
+26% +$3.75M 0.13% 90
2017
Q2
$27M Buy
4,742,491
+924,540
+24% +$6M 0.25% 73
2017
Q1
$31.2M Buy
3,817,951
+3,013,311
+374% +$20.8M 0.3% 71
2016
Q4
$4.29M Buy
+804,640
New +$4.08M 0.04% 98

Other funds holding CRHM

Mawer Investment Management's CRHM Position: Q4 2018 in Review

Mawer Investment Management sold out of CRH Medical Corporation (CRHM) in Q4 2018, closing a stake of 428,400 shares — an estimated $1.72M sold.

Mawer Investment Management first reported a position in CRHM in Q4 2016 and held it in 8 quarters. The position peaked at $31.2M in Q1 2017. 47 funds tracked by Wall St. Rank hold CRHM as of Q4 2018.

  • Mawer Investment Management reported no remaining CRH Medical Corporation position as of Q4 2018 after selling out during the quarter.
  • Mawer Investment Management sold 428,400 CRH Medical Corporation shares in Q4 2018, an estimated $1.72M.
  • Mawer Investment Management first reported a position in CRH Medical Corporation in Q4 2016 and held it in 8 quarters.
  • Mawer Investment Management's CRH Medical Corporation position peaked at $31.2M in Q1 2017.
  • 47 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q4 2018.

Based on Mawer Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.